Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

15.13
+0.22001.48%
Post-market: 15.130.00000.00%17:02 EDT
Volume:1.45M
Turnover:22.15M
Market Cap:1.34B
PE:-5.45
High:15.51
Open:15.04
Low:14.92
Close:14.91
Loading ...
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]